FMR LLC reports 10% Minerals Technologies (NYSE: MTX) stake
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 3,124,775.08 shares of Minerals Technologies Inc. common stock, representing 10.0% of the class as of the reporting date.
FMR LLC reports sole voting power over 3,121,533 shares and sole dispositive power over 3,124,775.08 shares. Abigail P. Johnson is also listed as a reporting person with sole dispositive power over the same 3,124,775.08 shares but no voting power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Positive
- None.
Negative
- None.
FAQ
What ownership stake does FMR LLC report in Minerals Technologies (MTX)?
FMR LLC reports beneficial ownership of 3,124,775.08 shares of Minerals Technologies common stock, representing 10.0% of the outstanding class. The firm also reports sole voting power over 3,121,533 of these shares and sole dispositive power over the full 3,124,775.08 shares.
Who are the reporting persons in the Minerals Technologies (MTX) Schedule 13G/A?
The reporting persons are FMR LLC and Abigail P. Johnson. FMR LLC is the institutional filer, while Johnson, a U.S. citizen, is listed with sole dispositive power over 3,124,775.08 shares but no voting power over Minerals Technologies common stock.
What does the Schedule 13G/A say about FMR LLC’s intent regarding control of Minerals Technologies?
The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Minerals Technologies, nor in connection with any transaction intended to achieve such a change in control.
What percentage threshold is disclosed for FMR LLC’s Minerals Technologies (MTX) holdings?
FMR LLC discloses beneficial ownership of 10.0% of the class of Minerals Technologies common stock. This level exceeds the 5% regulatory threshold that requires reporting on Schedule 13G, indicating a significant institutional stake in the issuer’s equity.